Twist Bioscience (TWST) Current Leases (2019 - 2026)

Twist Bioscience has disclosed Current Leases across 8 years of filings, most recently posting $10.4 million for Q1 2026.

• In Q1 2026, Current Leases fell 31.38% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (down 31.38% YoY), while the FY2025 annual figure was $13.8 million, down 6.64% from the prior year.
• Current Leases retreated to $10.4 million in Q1 2026, from $12.2 million in the prior quarter.
• Over the last five years, Current Leases for TWST reached as high as $15.5 million in Q2 2025 and fell as low as $10.4 million in Q1 2026.
• The 5-year median for Current Leases is $14.4 million (2022), against an average of $14.1 million.
• Annual changes were most pronounced in 2022 — Current Leases jumped 117.47% — and 2026, when it slumped 31.38%.
• A 5-year view of Current Leases shows it stood at $14.2 million in 2022, then grew by 4.08% to $14.8 million in 2023, then advanced by 1.5% to $15.0 million in 2024, then slipped by 18.55% to $12.2 million in 2025, then dropped by 14.7% to $10.4 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $10.4 million, $12.2 million, and $13.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.